Cancer prevention: from public health interventions to individual tailoring.

CHS National Cancer Control Center, Department of Community Medicine and Epidemiology, Carmel Medical Center, and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel Correspondence to Gad Rennert, MD, PhD, CHS National Cancer Control Center, Department of Community Medicine and Epidemiology, Carmel Medical Center, and B. Rappaport Faculty of Medicine, Technion, Haifa, Israel Tel: + 972 4825 0474; fax: + 972 4834 4358; e-mail: rennert@tx.technion.ac.il

[1]  H. Welch,et al.  Statins and the Risk of Colorectal Cancer , 2005, The New England journal of medicine.

[2]  M. Swift,et al.  Cancer predisposition of ataxia-telangiectasia heterozygotes. , 1990, Cancer genetics and cytogenetics.

[3]  P. Boffetta.  Epidemiology of environmental and occupational cancer , 2004, Oncogene.

[4]  J. Baron,et al.  Chemoprevention in gastrointestinal cancers: current status. , 2006, Basic & clinical pharmacology & toxicology.

[5]  J. Baron.  (Nutritional) chemoprevention of cancer: what's up? , 2006, Journal of the National Cancer Institute.

[6]  T. Paz-Elizur,et al.  DNA repair activity for oxidative damage and risk of lung cancer. , 2003, Journal of the National Cancer Institute.

[7]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[8]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[9]  S. Lippman,et al.  Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. , 2006, Cancer research.

[10]  W. Willett,et al.  Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index , 2004, Cancer Causes & Control.

[11]  M. Spitz,et al.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.

[12]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[13]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Cuzick.  Keynote comment: Chemoprevention of cancer--time to catch up with the cardiologists. , 2006, The Lancet. Oncology.

[15]  Frank Desiere.  Towards a systems biology understanding of human health: interplay between genotype, environment and nutrition. , 2004, Biotechnology annual review.

[16]  G. Rennert.  Are we taking the right approach in planning chemoprevention studies? , 2006, Nature Clinical Practice Oncology.

[17]  P. Brown.  Risk Assessment: Controversies and Management of Moderate‐ to High‐Risk Individuals , 2005, The breast journal.

[18]  G. Rennert.  Diet and cancer: where are we and where are we going? , 2003, Proceedings of the Nutrition Society.

[19]  L. Esserman,et al.  Breast Cancer Risk Assessment and Prevention: A Framework for Shared Decision‐Making Consultations , 2006, The breast journal.

[20]  Jack A. Taylor,et al.  Avoided and avoidable risks of cancer. , 1997, Carcinogenesis.